meRfi®-GM
Lacticaseibacillus casei Shirota (Yakult TM)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
There have been several reports of the ability of a fermented milk containing Lactobacillus casei strain Shirota (LcS) to prevent infectious disease and modulate immune function (e.g., natural killer cell activity)
Consumption of a probiotic drink containing Lactobacillus casei Shirota for 4 weeks by the elderly was reported to improve the tumoricidal activity of natural killer (NK) cells, increase the serum level of interleukin (IL)-10
(), and reduce the number of days on which fever was detected
Kushiro et al., 2019
…
References (Sources)
- Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population
- Decreased number of days of fever detection and duration of fever with continuous intake of a fermented milk drink: a randomized, double-blind, placebo-controlled study of elderly nursing home residents.
- Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged
- Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers.
- Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota
- Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models
- The effectiveness of Lactobacillus beverages in controlling infections among the residents of an aged care facility: a randomized placebo-controlled double-blind trial